NervGen Pharma Corp. (NGEN) News
Follow NervGen Pharma Corp. (NGEN) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 9 public stories across 3 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
NervGen Pharma: Expects to File Restated Audited Financial Statements for Year Ended Dec. 31, 2025, Including Restated 2024 Comparative Figure and Adjustment to Jan. 1, 2024, Opening Balances >NGEN
NervGen Pharma: Expects to File Restated Audited Financial Statements for Year Ended Dec. 31, 2025, Including Restated 2024 Comparative Figure and Adjustment to Jan. 1, 2024, Opening Balances >NGEN
NEWS | Sep 25, 2026, 08:35 PM UTC
L
NervGen Pharma: Restatement Expected to Reduce Previously Reported Accumulated Deficit >NGEN
NervGen Pharma: Restatement Expected to Reduce Previously Reported Accumulated Deficit >NGEN
NEWS | Sep 25, 2026, 08:34 PM UTC
L
NervGen Pharma: Restatement Expected to Reduce Previously Reported Warrant Liabilities >NGEN
NervGen Pharma: Restatement Expected to Reduce Previously Reported Warrant Liabilities >NGEN
NEWS | Sep 25, 2026, 08:34 PM UTC
L
NervGen Pharma: Restatement Expected to Reduce Previously Reported Stock-Based Compensation Expense >NGEN
NervGen Pharma: Restatement Expected to Reduce Previously Reported Stock-Based Compensation Expense >NGEN
EQUITY | Sep 25, 2026, 08:34 PM UTC
L
NervGen Pharma: Adjustments Have No Effect on Cash and Cash Equivalents, Cash Runway, or Business Operations >NGEN
NervGen Pharma: Adjustments Have No Effect on Cash and Cash Equivalents, Cash Runway, or Business Operations >NGEN
NEWS | Sep 25, 2026, 08:32 PM UTC
L
NervGen to Restate Previously Filed Financial Statements Recognizing Non-Cash Accounting Adjustments
NervGen to Restate Previously Filed Financial Statements Recognizing Non-Cash Accounting Adjustments
NEWS | Sep 25, 2026, 08:31 PM UTC
L
NervGen to host inaugural R&D Day on Sept. 30, 2026
NervGen (NGEN) announced it will host its inaugural R&D Day on September 30, 2026.
EQUITY | Sep 09, 2026, 11:32 AM UTC
L
NervGen to host inaugural R&D Day on September 30, 2026
NervGen said it will host its inaugural R&D Day on September 30, 2026.
EQUITY | Sep 09, 2026, 11:30 AM UTC
L
NervGen (NGEN) reports Q2 2026 financial results and business updates
NervGen (NGEN) reports its second quarter 2026 financial results and provides business updates, according to TradeXchange Newsdesk.
EARNINGS | Aug 13, 2026, 11:30 AM UTC